England - London • Corporate and commercial
Dechert LLP
Dechert LLP‘s corporate and securities practice group is noted for its equal strength across UK ECM and US securities deals, advising on complex cross-border equity transactions – particularly those on behalf of issuers in the life sciences sector. Patrick Lyons leads the international capital markets team from London.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Patrick Lyons' approachability, negotiation skills, problem-solving abilities, and teamwork make him an exceptional practitioner.'
Key clients
- Abivax SA
- EFG Hermes
- Renaissance Capital
- Toscafund Asset Management LLP
- Oxford BioDynamics plc
- Spark Advisory Partners
- Cenkos Securities plc
- Poxel SA
- Bank Audi
Work highlights
- Advised Abivax SA in connection with its successful pricing of an oversubscribed €130 million financing by way of a reserved capital increase, largest private placement for a biotech company listed on Euronext Paris.
- Advised EFG Hermes, as sole global coordinator, and the joint bookrunners on the EGP1.3 billion initial public offering (IPO) of Macro Group Pharmaceuticals, one of the largest Egyptian cosmeceuticals companies.
- Dechert advised Abivax SA in connection with a €49.2 million financing, comprising a private placement of shares and issuance of royalty certificates.
Practice head
The lawyer(s) leading their teams.
Patrick Lyons